Latin America and Asia boost flat first half for Novartis

Article Abstract:

Novartis' animal health product sales for first-half 2001 fell 5% to Swiss Francs 490 million, but operating income remained steady at Swiss Francs 66 million. Losses in the US and the UK were offset by gains in Asia and Latin America. Novartis has expanded its position in Eastern Europe by acquiring the prescription animal health product line of Selbruha (Budapest, Hungary at end-August 2001.

Switzerland, Hungary, Pharmaceutical industry, Mergers, acquisitions and divestments, Novartis AG, NVTSY, Selbruha

---

Provimi's Q3 net income up 34.4%

Article Abstract:

Provimi, of Rotterdam, the Netherlands, has posted third quarter sales of $326 million. Although the company's sales increased in almost all geographic regions, among the strongest areas were Central and Eastern Europe, the United States and France. The article provides additional information on the company's strategies.

Netherlands, Statistical Data Included, Provimi S.A.

---

Similar abstracts:

• Abstracts: Chemicals companies seek new formula for success. Chemicals. UK chemicals face bid threat
• Abstracts: Outsourcing Services and Post-Life Services. Infrastructure software stocks. Storage hardware & software stocks
• Abstracts: US expands anti-bioterrist measures. US, EU prepare for further biotech food dispute. EU-US experts urge stiffer rules for biotech foods
• Abstracts: Weighing up company profits. The hunt for the risk premium
• Abstracts: Scottish and Newcastle. Scottish & Newcastle. Wolverhampton & Dudley Breweries

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.